General Information of the Compound
| Compound ID |
CP0502620
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-bromo-N-m-tolylquinazolin-4-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(6-bromoquinazolin-4-yl)(3-methylphenyl)amine
6-bromo-N-(3-methylphenyl)-4-quinazolinamine
6-bromo-N-(3-methylphenyl)quinazolin-4-amine
6-bromo-N-m-tolylquinazolin-4-amine
AC1LEZQQ
AKOS002348862
BDBM50311883
CHEMBL1081537
EU-0043981
HMS2596L23
HMS3380E09
MCULE-2560701920
MLS000684595
MolPort-000-660-263
Neuro1_000540
Oprea1_147022
SCHEMBL4349199
SMR000268469
SR-01000485095
ST50477342
ZINC122234
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H12BrN3
|
||||||||||||||||||
| Molecular Weight |
314.186
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(Nc2ncnc3ccc(Br)cc23)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H12BrN3/c1-10-3-2-4-12(7-10)19-15-13-8-11(16)5-6-14(13)17-9-18-15/h2-9H,1H3,(H,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CGCSONSXFOSORP-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound